WHO Collaborating Centre for Reference and Research on Influenza, Victoria Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Elizabeth Street, Melbourne, VIC, Australia.
Department of Microbiology, Royal Children's Hospital, Flemington Road, Parkville, Melbourne, VIC, Australia.
J Virol Methods. 2021 Aug;294:114171. doi: 10.1016/j.jviromet.2021.114171. Epub 2021 May 10.
Respiratory syncytial virus (RSV) is a common cause of acute respiratory disease worldwide, especially in young children. The World Health Organization (WHO) has initiated an RSV Surveillance Pilot program that aims to perform worldwide RSV surveillance, requiring the development of reliable and rapid molecular methods to detect and identify RSV. A duplex real-time RT-PCR assay developed for simultaneous detection of both A and B subtypes of RSV was included as part of this program. This duplex assay targeted a conserved region of the RSV polymerase gene and was validated for analytical sensitivity, specificity, reproducibility and clinical performance with a wide range of respiratory specimens. The assay was highly specific for RSV and did not react with non-RSV respiratory pathogens, including the SARS-CoV-2 virus.
呼吸道合胞病毒(RSV)是全球范围内引起急性呼吸道疾病的常见原因,尤其是在幼儿中。世界卫生组织(WHO)已启动呼吸道合胞病毒监测试点计划,旨在进行全球范围内的 RSV 监测,这需要开发可靠和快速的分子方法来检测和鉴定 RSV。该计划包括一种用于同时检测 RSV A 和 B 亚型的双靶实时 RT-PCR 检测方法。该双靶检测方法针对 RSV 聚合酶基因的保守区域,并且已针对分析灵敏度、特异性、重现性和广泛的呼吸道标本的临床性能进行了验证。该检测方法对 RSV 具有高度特异性,并且不会与非 RSV 呼吸道病原体反应,包括 SARS-CoV-2 病毒。